Xconomy National

Archives

by in

Entry	Author	Date	Location
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO	Luke Timmerman	12/06/11	Seattle
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test	Luke Timmerman	09/24/11	San Francisco
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News	Luke Timmerman	09/22/11	Seattle
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic	Luke Timmerman	09/21/11	Seattle
Theraclone Snaps Up $10.6M Financing	Luke Timmerman	09/08/11	Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News	Luke Timmerman	09/08/11	Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing	Luke Timmerman	09/06/11	Seattle
Xoma CEO Resigns After Four-Year Push To Go Commercial	Luke Timmerman	08/31/11	San Francisco
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies	Luke Timmerman	08/29/11	Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul	Luke Timmerman	07/05/11	Seattle
Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News	Erin Kutz	06/01/11	Boston
ImmunoGen Grabs $84M	Luke Timmerman	05/20/11	Boston
SeaGen Ends March With $456M Cash	Luke Timmerman	05/05/11	Seattle
Dyax, FivePrime Cut Antibody Deal	Luke Timmerman	04/26/11	Boston
Genmab Expands SeaGen Alliance	Luke Timmerman	04/19/11	Seattle
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol	Luke Timmerman	03/02/11	Seattle
Amgen Pushes Ahead With ‘Son of Dmab’ For Treating Broken, Frail Bones	Luke Timmerman	02/09/11	National
Secretive Biotech Arsanis Raises $9.6M	Ryan McBride	02/08/11	Boston
Seattle Genetics Reloads Cash Reserves With $155M, On Cusp of Selling First Drug	Luke Timmerman	02/02/11	Seattle
Scripps President Richard Lerner To Step Down, Be Replaced by Berkeley Chemist, Sources Say	Luke Timmerman	01/31/11	San Diego
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars	Luke Timmerman	01/28/11	National
SEC Accuses Seattle Genetics Employee of Insider Trading	Luke Timmerman	01/21/11	Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections	Luke Timmerman	01/18/11	Seattle
Seattle Genetics Gets Some Love on National TV, as Cancer Drug Nears Market	Luke Timmerman	01/14/11	Seattle
Entrega Emerges From Enlight	Gregory T. Huang	01/10/11	Boston
Xoma Nabs $35M Upfront Deal	Luke Timmerman	01/04/11	San Francisco
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners	Ryan McBride	12/15/10	Boston
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s	Luke Timmerman	12/05/10	Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News	Luke Timmerman	11/18/10	Seattle
Montgomery Joins Alder Board	Luke Timmerman	11/01/10	Seattle
Page 1 of 3	next page »